PSNPA Dinner Program: Selecting a first-choice therapy for systolic HF: The growing body of evidence
Seastar Restaurant & Raw Bar
205 108th Avenue Northeast
Bellevue, WA 98004
Wednesday, February 12, 2020 at 6:00pm PT - 7:00pm PT
This event has ended.
Info
Topic
Selecting a first-choice therapy for systolic HF: The growing body of evidence
Speaker(s)
Erik Kellison PharmD
Additional Information
*** The official registration window has closed for this event, however there are limited spaces still available. If you would like to attend this dinner meeting, please email Ben MIller directly at BenMillerNP@hotmail.com
Thanks
Ben
********************************************************************************************
Heart failure (HF) is a chronic and debilitating condition that affects more than 5 billion people world wide. Changes in the management of HF are evolving and include primary care management. Entresto is a combination medication that has demonstrated excellent outcomes for people with HF.
By continuing with this registration, you authorize the PSNPA to release your registration information to the host sponsor in accordance with PHARMA guidelines.